Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2010
08/26/2010WO2010094463A1 Means and methods for manufacturing highly pure neurotoxin
08/26/2010WO2010077672A3 Control of mosquito larvae with bti toxins and tmof
08/26/2010WO2010076809A3 Glp-1 analogs and uses thereof
08/26/2010WO2010075983A8 Process for the production of bivalirudin
08/26/2010WO2010074575A3 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv.
08/26/2010WO2010073104A3 Improving cognitive function
08/26/2010WO2010045648A3 Methods for removing nicotine and other alkaloids from soluble leaf proteins in solanaceous and other plant species
08/26/2010WO2010027828A3 Pd-1 antagonists and methods of use thereof
08/26/2010WO2010002478A4 Glycopeptide and uses thereof
08/26/2010WO2009140469A3 Dosage regimen comprising ap02l/trail, anti-vegf / anti-cd20 and chemotherapy to treat nsclc or non-hodgkin's lymphoma, respectively
08/26/2010WO2009136293A3 Genes and methods for increasing disease resistance in plants
08/26/2010WO2009094561A8 Induced internalization of surface receptors
08/26/2010WO2009087110A8 Secretable hiv entry inhibitory peptides for therapy of hiv infection
08/26/2010US20100218282 Nucleic acid molecules from rice controlling abiotic stress tolerance
08/26/2010US20100218280 Defensin-Encoding Nucleic Acid Molecules Derived From Nicotiana Alata, Uses Therefor and Transgenic Plants Comprising Same
08/26/2010US20100218277 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained
08/26/2010US20100218276 Maize multidrug resistance-associated protein polynucleotides and methods of use
08/26/2010US20100218273 Yield Enhancement In Plants By Modulation Of Maize Mads Box Transcription Factor Silky1
08/26/2010US20100218267 Methods for Producing Antibodies
08/26/2010US20100218265 Immune system mediator
08/26/2010US20100218263 Transgenic mollusk and method for producing the same
08/26/2010US20100217032 Process for preparing pravastatin
08/26/2010US20100216976 Sodium-independent transporter carrying acidic amino acid and its gene
08/26/2010US20100216972 RNAi Inhibition of Alpha-ENaC Expression
08/26/2010US20100216971 RNAi Inhibition of Alpha-ENaC Expression
08/26/2010US20100216717 Hypoallergenic Mutant Polypeptides Based on Fish Parvalbumin
08/26/2010US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway
08/26/2010US20100216715 FGF21 Derivatives With Albumin Binder A-B-C-D-E- And Their Use
08/26/2010US20100216714 Natriuretic compounds, conjugates, and uses thereof
08/26/2010US20100216713 Novel compositions and methods in cancer associated with altered expression of prlr
08/26/2010US20100216712 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof
08/26/2010US20100216711 Protease-Stable, Cell Wall-Lysing Enzymes
08/26/2010US20100216710 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
08/26/2010US20100216708 Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses
08/26/2010US20100216704 Novel genes and proteins that home to developing microvessels
08/26/2010US20100216703 Inhibitors of PDE4 and Methods of Use
08/26/2010US20100216702 Vegf analogs and methods of use
08/26/2010US20100216701 Protein Kinase C Inhibitors for Prevention of Insulin Resistance and Type 2 Diabetes
08/26/2010US20100216695 Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders
08/26/2010US20100216691 Protease Stabilized, Pegylated Insulin Analogues
08/26/2010US20100216690 Pegylated Single-Chain Insulin
08/26/2010US20100216239 Isolated nature-identical collagen
08/26/2010US20100216213 Polypeptides Having Glucoamylase Activity and Polynucleotides Encoding Same
08/26/2010US20100216212 Anti-obesity agent and anti-obesity food
08/26/2010US20100216189 Synthetic repetitive proteins, the production and use thereof
08/26/2010US20100216187 Amino acid sequences that bind to a desired molecule in a conditional manner
08/26/2010US20100216164 Mammalian prickle gene
08/26/2010US20100216161 Method for identifying protease inhibitors
08/26/2010US20100216154 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
08/26/2010US20100216148 Novel tumor marker
08/26/2010US20100216140 Novel Human Dickkopf-Related Protein and Nucleic Acid Molecules and uses Therefor
08/26/2010US20100215693 Immunological herpes simplex virus antigens and methods for use thereof
08/26/2010US20100215692 Dengue Chimeric Viruses
08/26/2010US20100215690 Circovirus sequences associated with piglet weight loss disease (pwd)
08/26/2010US20100215684 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
08/26/2010US20100215683 Protective antigens for group b streptococcus hypervirulent strains
08/26/2010US20100215682 Deletion of the beta 20-21 loop in hiv gp120 exposes the cd4 binding site for improved antibody binding and antibody induction
08/26/2010US20100215681 Fusion proteins comprising hiv-1 tat and/or nef proteins
08/26/2010US20100215680 Replikin peptides and antibodies therefor
08/26/2010US20100215677 Pdz domain interactions and lipid rafts
08/26/2010US20100215676 Kdr peptides and vaccines comprising the same
08/26/2010US20100215675 Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
08/26/2010US20100215667 Methods and compositions of treatment for modulating the immune system of animals
08/26/2010US20100215664 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6 -mediated signalling
08/26/2010US20100215656 Deletions in domain ii of pseudomonas exotoxin a that remove immunogenic epitopes
08/26/2010US20100215655 Angiogenesis-inhibiting chimeric proteins and the use
08/26/2010US20100215615 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
08/26/2010US20100215593 Ionic complexes
08/26/2010US20100215581 Contrast agents for detecting prostate cancer
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100215572 Methods of treatment using ldcam
08/26/2010CA2790292A1 Novel kinase-start gene conferring resistance to plant disease and transgenic plants comprising it
08/26/2010CA2767752A1 Improved anti-serum albumin binding variants
08/26/2010CA2753294A1 Proproteins and methods of use thereof
08/26/2010CA2753181A1 Target-activated cell/tissue penetrating peptide for delivery of impermeable compounds and use thereof
08/26/2010CA2753172A1 Means for purifying a protein of blood plasma and methods for implementing same
08/26/2010CA2753170A1 Means for purifying a coagulation protein, and methods for implementing same
08/26/2010CA2753130A1 Improved anti-serum albumin binding variants
08/26/2010CA2753099A1 Modifications of cupredoxin derived peptides and methods of use thereof
08/26/2010CA2753048A1 Streptavidin having low immunogenicity and use thereof
08/26/2010CA2752976A1 Yeast cells expressing an exogenous cellulosome and methods of using the same
08/26/2010CA2752809A1 Inactivated dengue virus vaccine with aluminium-free adjuvant
08/26/2010CA2752729A1 Cell culture media containing combinations of proteins
08/26/2010CA2752679A1 Isolated monocyte populations and related therapeutic applications
08/26/2010CA2752560A1 Foxm1 peptides and vaccines containing the same
08/26/2010CA2751673A1 Analogues of neuropeptide y having proline substitution at position 34
08/26/2010CA2751636A1 Analogues of neuropeptide y having at least one synthetic amino acid substitution
08/26/2010CA2751477A1 Antibody molecules having specificity for human ox40
08/26/2010CA2751311A1 Means and methods for manufacturing highly pure neurotoxin
08/26/2010CA2750985A1 Methods and compositions for diagnosis and treatment of cancer
08/25/2010EP2221620A2 Polypeptide biomarkers for diagnosing Alzheimer's disease
08/25/2010EP2221383A1 Nucleotide sequence encoding anti-fungal polypeptide
08/25/2010EP2221382A2 Proteins associated with abiotic stress response and homologs
08/25/2010EP2221381A2 Promoters for regulation of plant expression
08/25/2010EP2221379A1 Method of identifying compounds that induce or inhibit endoplasmic reticulum stress or oxidative stress
08/25/2010EP2221375A1 Methods and compositions for diagnosis and treatment of cancer
08/25/2010EP2221369A1 Mutant nucleic acid related to chronic myeloproliferative disorder, and method of evaluating chronic myeloproliferative disorder
08/25/2010EP2221368A1 West nile virus vaccine, and method for production thereof
08/25/2010EP2221367A1 Protein-responsive translation control system utilizing rna-protein interaction motif
08/25/2010EP2221361A2 Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
1 ... 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 ... 2916